SlateStone Wealth’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,386
| Closed | -$304K | – | 204 |
|
|
2022
Q1 | $304K | Sell |
3,386
-14,750
| -81% | -$1.32M | 0.07% | 144 |
|
|
2021
Q4 | $2.03M | Hold |
18,136
| – | – | 0.43% | 56 |
|
|
2021
Q3 | $2.28M | Sell |
18,136
-3,600
| -17% | -$453K | 0.52% | 45 |
|
|
2021
Q2 | $2.94M | Sell |
21,736
-300
| -1% | -$40.6K | 0.67% | 37 |
|
|
2021
Q1 | $2.99M | Hold |
22,036
| – | – | 0.74% | 38 |
|
|
2020
Q4 | $3.1M | Buy |
22,036
+150
| +0.7% | +$21.1K | 0.77% | 33 |
|
|
2020
Q3 | $2.44M | Hold |
21,886
| – | – | 0.53% | 54 |
|
|
2020
Q2 | $2.45M | Hold |
21,886
| – | – | 0.55% | 53 |
|
|
2020
Q1 | $1.7M | Sell |
21,886
-400
| -2% | -$31K | 0.48% | 58 |
|
|
2019
Q4 | $2.12M | Sell |
22,286
-450
| -2% | -$42.8K | 0.48% | 55 |
|
|
2019
Q3 | $1.73M | Sell |
22,736
-85
| -0.4% | -$6.48K | 0.51% | 53 |
|
|
2019
Q2 | $2M | Hold |
22,821
| – | – | 0.56% | 46 |
|
|
2019
Q1 | $2.07M | Buy |
22,821
+835
| +4% | +$75.6K | 0.63% | 37 |
|
|
2018
Q4 | $1.58M | Buy |
+21,986
| New | +$1.58M | 0.73% | 38 |
|